Micah Luftig

33PUBLICATIONS
163CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyBehavioural epidemiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 24, 2026
SIRT2 deacylase modulators control B cell metabolic reprogramming in EBV infection and mitogenic activation.

|May 27, 2026
Epstein-Barr Virus-Positive Primary CNS Lymphoma in a Patient Receiving Mycophenolate Mofetil: Diagnostic and Therapeutic Considerations.

|Mar 23, 2026
Single-cell profiling of HDAC inhibitor-induced EBV lytic heterogeneity defines abortive and refractory states in B lymphoblasts.

Lauren E Haynes, Ashley P Barry, Micah A Luftig

|Dec 25, 2025
Dissecting Epstein-Barr Virus Dependence Across Diverse Infected Cell Models.

Alexandria Bartlett, Camille Krejdovsky, Guang Yang

|Nov 24, 2025
HIV-associated non-Hodgkin lymphoma tumor-microenvironment axes differ by EBV status across cellular origins.

Amy Chadburn, Maria Montserrat Aguilar Hernandez, Joanne Dai

|Nov 24, 2025
Single-Cell Profiling of HDAC Inhibitor-Induced EBV Lytic Heterogeneity Defines Abortive and Refractory States in B Lymphoblasts.

Lauren E Haynes, Ashley P Barry, Micah A Luftig

Pageof 6

Frequent Collaborators

6 joint publications

W Paul Duprex

6 joint publications

Felicia Goodrum

6 joint publications

Gary Chan

6 joint publications

Arturo Casadevall